BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Mark E. Lockhart, Andrew D. Smith. Fatty Liver Disease: Artificial Intelligence Takes on the ChallengeRadiology 2020; 295(2): 351 doi: 10.1148/radiol.2020200058
2
Yong-Giun Kim, Gyung-Min Park, Seung Bum Lee, Dong Hyun Yang, Joon-Won Kang, Tae-Hwan Lim, Hong-Kyu Kim, Jaewon Choe, Seung-Whan Lee, Young-Hak Kim. Association of gamma-glutamyl transferase with subclinical coronary atherosclerosis and cardiac outcomes in non-alcoholicsScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-75078-6
3
John A. Dougherty, Erenie Guirguis, Krisy-Ann Thornby. A Systematic Review of Newer Antidiabetic Agents in the Treatment of Nonalcoholic Fatty Liver DiseaseAnnals of Pharmacotherapy 2021; 55(1): 65 doi: 10.1177/1060028020935105
4
Evy Yunihastuti, Lusiani Rusdi, Muhammad Syahrir Azizi, Riwanti Estiasari, Chyntia Olivia Maurine Jasirwan, Endah Ayu T. Wulandari, Dyah Purnamasari, Mutiara Shinta Noviar, Sally Aman Nasution. Effect of atorvastatin on subclinical atherosclerosis in virally-suppressed HIV-infected patients with CMV seropositivity: a randomized double-blind placebo-controlled trialF1000Research 2021; 10: 151 doi: 10.12688/f1000research.28262.1
5
Man Zhang. Imaging Biomarkers for Nonalcoholic Fatty Liver DiseaseAcademic Radiology 2019; 26(7): 869 doi: 10.1016/j.acra.2019.04.001
6
Alyson Kaplan, Tracey G. Simon, Jacqueline B. Henson, Thomas Wang, Hui Zheng, Stephanie A. Osganian, Russell Rosenblatt, Jordan Lake, Kathleen E. Corey. Brief Report: Relationship Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease in Persons With HIVJAIDS Journal of Acquired Immune Deficiency Syndromes 2020; 84(4): 400 doi: 10.1097/QAI.0000000000002359
7
Roberta Catania, Alessandro Furlan, Andrew D. Smith, Jaideep Behari, Mitchell E. Tublin, Amir A. Borhani. Diagnostic value of MRI-derived liver surface nodularity score for the non-invasive quantification of hepatic fibrosis in non-alcoholic fatty liver diseaseEuropean Radiology 2021; 31(1): 256 doi: 10.1007/s00330-020-07114-y
8
Szilárd Váncsa, Dávid Németh, Péter Hegyi, Zsolt Szakács, Péter Jeno Hegyi, Dániel Pécsi, Alexandra Mikó, Bálint Erőss, Adrienn Erős, Gabriella Pár. Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease Worsen the Outcome in Acute Pancreatitis: A Systematic Review and Meta-AnalysisJournal of Clinical Medicine 2020; 9(9): 2698 doi: 10.3390/jcm9092698
9
Manu V. Chakravarthy, Mohammad S. Siddiqui, Mikael F. Forsgren, Arun J. Sanyal. Harnessing Muscle–Liver Crosstalk to Treat Nonalcoholic SteatohepatitisFrontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.592373
10
Reham M. Gameaa, Nehad Hawash, Rehab Badawi, Sherief Abd-Elsalam, Gamal K. Kasem, El-Sayed A. Wasfy. Assessment of Hepatic Steatosis in Patients with Chronic Hepatitis B Using Fibroscan and its Relation to Insulin ResistanceThe Open Biomarkers Journal 2019; 9(1): 70 doi: 10.2174/1875318301909010070
11
Maryam Ghadimi, Roya Rezvani Habibabadi, Bita Hazhirkarzar, Mohammadreza Shaghaghi, Sanaz Ameli, Pegah Khoshpouri, Mounes Aliyari Ghasabeh, Ahmet Gurakar, Timothy M. Pawlik, Ihab R. Kamel. Advances in Imaging of Diffuse Parenchymal Liver DiseaseJournal of Clinical Gastroenterology 2020; 54(8): 682 doi: 10.1097/MCG.0000000000001380
12
Yoo Bin Seo, A Lum Han. Association of the Serum Uric Acid-to-Creatinine Ratio with Nonalcoholic Fatty Liver Disease Diagnosed by Computed TomographyMetabolic Syndrome and Related Disorders 2021; 19(2): 70 doi: 10.1089/met.2020.0086
13
Javier Espíldora-Hernández, Tania Díaz-Antonio, Javier Baena-Espinar, Inmaculada Alonso-Calderón, José Rioja, Emilio Alba-Conejo, Pedro Valdivielso, Miguel-Ángel Sánchez-Chaparro. Subclinical Arteriosclerosis is Associated with Common Vascular Risk Factors in Long-Term Survivors of Testicular CancerJournal of Clinical Medicine 2020; 9(4): 971 doi: 10.3390/jcm9040971
14
Danoob Dalili, Alberto Bazzocchi, Daniel E. Dalili, Giuseppe Guglielmi, Amanda Isaac. The role of body composition assessment in obesity and eating disordersEuropean Journal of Radiology 2020; 131: 109227 doi: 10.1016/j.ejrad.2020.109227
15
Matti O. Ruuskanen, Fredrik Åberg, Ville Männistö, Aki S. Havulinna, Guillaume Méric, Yang Liu, Rohit Loomba, Yoshiki Vázquez-Baeza, Anupriya Tripathi, Liisa M. Valsta, Michael Inouye, Pekka Jousilahti, Veikko Salomaa, Mohit Jain, Rob Knight, Leo Lahti, Teemu J. Niiranen. Links between gut microbiome composition and fatty liver disease in a large population sampleGut Microbes 2021; 13(1): 1 doi: 10.1080/19490976.2021.1888673
16
Janna L. Morrison, Oyekoya T. Ayonrinde, Alison S. Care, Geoffrey D. Clarke, Jack R.T. Darby, Anna L. David, Justin M. Dean, Stuart B. Hooper, Marcus J. Kitchen, Christopher K. Macgowan, Andrew Melbourne, Erin V McGillick, Charles A. McKenzie, Navin Michael, Nuruddin Mohammed, Suresh Anand Sadananthan, Eric Schrauben, Timothy R.H. Regnault, S. Sendhil Velan. Seeing the fetus from a DOHaD perspective: discussion paper from the advanced imaging techniques of DOHaD applications workshop held at the 2019 DOHaD World CongressJournal of Developmental Origins of Health and Disease 2021; 12(2): 153 doi: 10.1017/S2040174420000884
17
Waqas B. Khalid, Nadim Farhat, Linda Lavery, Josh Jarnagin, James P. Delany, Kang Kim. Non-invasive Assessment of Liver Fat in ob/ob Mice Using Ultrasound-Induced Thermal Strain Imaging and Its Correlation with Hepatic Triglyceride ContentUltrasound in Medicine & Biology 2021; 47(4): 1067 doi: 10.1016/j.ultrasmedbio.2020.12.014
18
Helena Castañé, Gerard Baiges-Gaya, Anna Hernández-Aguilera, Elisabet Rodríguez-Tomàs, Salvador Fernández-Arroyo, Pol Herrero, Antoni Delpino-Rius, Nuria Canela, Javier A. Menendez, Jordi Camps, Jorge Joven. Coupling Machine Learning and Lipidomics as a Tool to Investigate Metabolic Dysfunction-Associated Fatty Liver Disease. A General OverviewBiomolecules 2021; 11(3): 473 doi: 10.3390/biom11030473
19
Somaya Albhaisi, Arun J. Sanyal. Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to DatePharmaceutical Medicine 2019; 33(6): 451 doi: 10.1007/s40290-019-00305-z
20
Justin J. O’Sullivan, Nathaniel H. O. Harder, Marie C. Heffern. Detecting liver disease via an endogenous pigmentNature Biomedical Engineering 2020; 4(8): 761 doi: 10.1038/s41551-020-0601-2
21
Jeffrey Budd, Kenneth Cusi. Nonalcoholic Fatty Liver Disease: What Does the Primary Care Physician Need to Know?The American Journal of Medicine 2020; 133(5): 536 doi: 10.1016/j.amjmed.2020.01.007
22
Prevalence of non‐alcoholic fatty liver disease and factors associated with it in Indian women with a history of gestational diabetes mellitusJournal of Diabetes Investigation 2021; 12(5): 877 doi: 10.1111/jdi.13411
23
Fuad Jafarov, Eda Kaya, Alev Bakir, Fatih Eren, Yusuf Yilmaz. The diagnostic utility of fibrosis-4 or nonalcoholic fatty liver disease fibrosis score combined with liver stiffness measurement by fibroscan in assessment of advanced liver fibrosis: a biopsy-proven nonalcoholic fatty liver disease studyEuropean Journal of Gastroenterology & Hepatology 2020; 32(5): 642 doi: 10.1097/MEG.0000000000001573
24
Tasnim Alkayyali, Lubna Qutranji, Eda Kaya, Alev Bakir, Yusuf Yilmaz. Clinical utility of noninvasive scores in assessing advanced hepatic fibrosis in patients with type 2 diabetes mellitus: a study in biopsy-proven non-alcoholic fatty liver diseaseActa Diabetologica 2020; 57(5): 613 doi: 10.1007/s00592-019-01467-7
25
Zhen Huang, Lei‐Ming Wu, Jie‐Lei Zhang, Abdelkarim Sabri, Shou‐Jun Wang, Gui‐Jun Qin, Chang‐Qing Guo, Hong‐Tao Wen, Bin‐Bin Du, Dian‐Hong Zhang, Ling‐Yao Kong, Xin‐Yu Tian, Rui Yao, Ya‐Peng Li, Cui Liang, Peng‐Cheng Li, Zheng Wang, Jin‐Yan Guo, Ling Li, Jian‐Zeng Dong, Yan‐Zhou Zhang. Dual Specificity Phosphatase 12 Regulates Hepatic Lipid Metabolism Through Inhibition of the Lipogenesis and Apoptosis Signal–Regulating Kinase 1 PathwaysHepatology 2019; 70(4): 1099 doi: 10.1002/hep.30597
26
Arinc Ozturk, Ramin Mohammadi, Theodore T. Pierce, Sagar Kamarthi, Manish Dhyani, Joseph R. Grajo, Kathleen E. Corey, Raymond T. Chung, Atul K. Bhan, Jagpreet Chhatwal, Anthony E. Samir. Diagnostic Accuracy of Shear Wave Elastography as a Non-invasive Biomarker of High-Risk Non-alcoholic Steatohepatitis in Patients with Non-alcoholic Fatty Liver DiseaseUltrasound in Medicine & Biology 2020; 46(4): 972 doi: 10.1016/j.ultrasmedbio.2019.12.020
27
Andrew J. Krentz, Pierre Bedossa. Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease2019; : 245 doi: 10.1007/978-3-030-11748-1_10
28
A. P. Gonchar, V. A. Gombolevskij, A. B. Elizarov, N. S. Kulberg, V. G. Klyashtorny, V. Yu. Chernina, V. Yu. Bosin, S. P. Morozov. Liver density in routine and low-dose computed tomography: the effect of image noise on measurement accuracyMedical Visualization 2020; 24(1): 39 doi: 10.24835/1607-0763-2020-1-39-47
29
Parul Kamboj, Soumalya Sarkar, Sonu Kumar Gupta, Neema Bisht, Deepika Kumari, Md. Jahangir Alam, Sagar Barge, Bhaswati Kashyap, Barsha Deka, Simanta Bharadwaj, Seydur Rahman, Partha Pratim Dutta, Jagat C. Borah, Narayan Chandra Talukdar, Sanjay K. Banerjee, Yashwant Kumar. Methanolic Extract of Lysimachia Candida Lindl. Prevents High-Fat High-Fructose-Induced Fatty Liver in Rats: Understanding the Molecular Mechanism Through Untargeted Metabolomics StudyFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.653872
30
Ekram W. Abd El-Wahab, Rehab A. Zein El-Abedin, Walid M. Ahmed, Hanan Z. Shatat. Validation of a Non-Laboratory Based Screening Tool for Predicting Non-Alcoholic Fatty Liver Disease in an Egyptian SettingThe American Journal of the Medical Sciences 2020; 360(6): 662 doi: 10.1016/j.amjms.2020.06.020
31
Julio Plaza-Díaz, Patricio Solis-Urra, Jerónimo Aragón-Vela, Fernando Rodríguez-Rodríguez, Jorge Olivares-Arancibia, Ana I. Álvarez-Mercado. Insights into the Impact of Microbiota in the Treatment of NAFLD/NASH and Its Potential as a Biomarker for Prognosis and DiagnosisBiomedicines 2021; 9(2): 145 doi: 10.3390/biomedicines9020145
32
Ahmad Khonche, Hasan Fallah Huseini, Mahdi Gholamian, Reza Mohtashami, Farzaneh Nabati, Saeed Kianbakht. Standardized Nigella sativa seed oil ameliorates hepatic steatosis, aminotransferase and lipid levels in non-alcoholic fatty liver disease: A randomized, double-blind and placebo-controlled clinical trialJournal of Ethnopharmacology 2019; 234: 106 doi: 10.1016/j.jep.2019.01.009
33
Nirmalya Sinha, Saptarshi Mukhopadhyay, Manabendra Sau. Metabolic syndrome is not uncommon among lean non-alcoholic fatty liver disease patients as compared with those with obesityIndian Journal of Gastroenterology 2020; 39(1): 75 doi: 10.1007/s12664-020-01020-3
34
Anugayathri Jawahar, Beverly Gonzalez, Neelam Balasubramanian, William Adams, Ari Goldberg. Comparison of computed tomography hepatic steatosis criteria for identification of abnormal liver function and clinical risk factors, in incidentally noted fatty liverEuropean Journal of Gastroenterology & Hepatology 2020; 32(2): 216 doi: 10.1097/MEG.0000000000001502
35
Charalampia Amerikanou, Stavroula Kanoni, Andriana C. Kaliora, Angela Barone, Mladen Bjelan, Giuseppe D'Auria, Aristea Gioxari, María José Gosalbes, Sofia Mouchti, Maria G. Stathopoulou, Beatriz Soriano, Stefan Stojanoski, Rajarshi Banerjee, Maria Halabalaki, Eleni V. Mikropoulou, Aimo Kannt, John Lamont, Carlos Llorens, Fernando Marascio, Miriam Marascio, Francisco J. Roig, Ilias Smyrnioudis, Iraklis Varlamis, Sophie Visvikis‐Siest, Milan Vukic, Natasa Milic, Milica Medic‐Stojanoska, Lucia Cesarini, Jonica Campolo, Amalia Gastaldelli, Panos Deloukas, Maria Giovanna Trivella, M. Pilar Francino, George V. Dedoussis. Effect of Mastiha supplementation on NAFLD: The MAST4HEALTH Randomised, Controlled TrialMolecular Nutrition & Food Research 2021; : 2001178 doi: 10.1002/mnfr.202001178
36
Mayur Virarkar, Ajaykumar C. Morani, Melissa W. Taggart, Priya Bhosale. Liver Fibrosis AssessmentSeminars in Ultrasound, CT and MRI 2021;  doi: 10.1053/j.sult.2021.03.003
37
Cristina M. Muzica, Catalin Sfarti, Anca Trifan, Sebastian Zenovia, Tudor Cuciureanu, Robert Nastasa, Laura Huiban, Camelia Cojocariu, Ana-Maria Singeap, Irina Girleanu, Stefan Chiriac, Carol Stanciu, Branka Filipović. Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: A Bidirectional RelationshipCanadian Journal of Gastroenterology and Hepatology 2020; 2020: 1 doi: 10.1155/2020/6638306
38
Louise J. M. Alferink, Nicole S. Erler, Robert J. de Knegt, Harry L. A. Janssen, Herold J. Metselaar, Sarwa Darwish Murad, Jessica C. Kiefte-de Jong. Adherence to a plant-based, high-fibre dietary pattern is related to regression of non-alcoholic fatty liver disease in an elderly populationEuropean Journal of Epidemiology 2020; 35(11): 1069 doi: 10.1007/s10654-020-00627-2
39
P.-Y. Brillet. Dépistage du cancer broncho-pulmonaire: les « big 3 » et les autresRevue des Maladies Respiratoires Actualités 2019; 11(2): 107 doi: 10.1016/S1877-1203(19)30041-2
40
Asad Izziddin Dajani, Branko Popovic. Essential phospholipids for nonalcoholic fatty liver disease associated with metabolic syndrome: A systematic review and network meta-analysisWorld Journal of Clinical Cases 2020; 8(21): 5235-5249 doi: 10.12998/wjcc.v8.i21.5235
41
Mercedes del Río-Moreno, Emilia Alors-Pérez, Sandra González-Rubio, Gustavo Ferrín, Oscar Reyes, Manuel Rodríguez-Perálvarez, Marina E Sánchez-Frías, Rafael Sánchez-Sánchez, Sebastián Ventura, José López-Miranda, Rhonda D Kineman, Manuel de la Mata, Justo P Castaño, Manuel D Gahete, Raúl M Luque. Dysregulation of the Splicing Machinery Is Associated to the Development of Nonalcoholic Fatty Liver DiseaseThe Journal of Clinical Endocrinology & Metabolism 2019; 104(8): 3389 doi: 10.1210/jc.2019-00021
42
Jeong-Ju Yoo, Yong Seok Lim, Min Sung Kim, Bora Lee, Bo-Yeon Kim, Zisun Kim, Ji Eun Lee, Min Hee Lee, Sang Gyune Kim, Young Seok Kim, Hakan Buyukhatipoglu. Risk of fatty liver after long-term use of tamoxifen in patients with breast cancerPLOS ONE 2020; 15(7): e0236506 doi: 10.1371/journal.pone.0236506
43
J.A. Weintraub, G. Lopez Mitnik, B.A. Dye. Oral Diseases Associated with Nonalcoholic Fatty Liver Disease in the United StatesJournal of Dental Research 2019; 98(11): 1219 doi: 10.1177/0022034519866442
44
Dominika Maciejewska, Joanna Palma, Karolina Dec, Karolina Skonieczna-Żydecka, Izabela Gutowska, Małgorzata Szczuko, Karolina Jakubczyk, Ewa Stachowska. Is the Fatty Acids Profile in Blood a Good Predictor of Liver Changes? Correlation of Fatty Acids Profile with Fatty Acids Content in the LiverDiagnostics 2019; 9(4): 197 doi: 10.3390/diagnostics9040197
45
Soumalya Sarkar, Sankarsan Bhattacharya, Md. Jahangir Alam, Rajni Yadav, Sanjay K. Banerjee. Hypoxia aggravates non-alcoholic fatty liver disease in presence of high fat choline deficient diet: A pilot studyLife Sciences 2020; 260: 118404 doi: 10.1016/j.lfs.2020.118404
46
Fatemeh Homayounieh, Sanjay Saini, Leila Mostafavi, Ruhani Doda Khera, Michael Sühling, Bernhard Schmidt, Ramandeep Singh, Thomas Flohr, Mannudeep K. Kalra. Accuracy of radiomics for differentiating diffuse liver diseases on non-contrast CTInternational Journal of Computer Assisted Radiology and Surgery 2020; 15(10): 1727 doi: 10.1007/s11548-020-02212-0
47
Alejandro Campos-Murguía, Astrid Ruiz-Margáin, José A González-Regueiro, Ricardo U Macías-Rodríguez. Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver diseaseWorld Journal of Gastroenterology 2020; 26(39): 5919-5943 doi: 10.3748/wjg.v26.i39.5919
48
Waqas B. Khalid, Xucai Chen, Kang Kim. Multifocus Thermal Strain Imaging Using a Curved Linear Array Transducer for Identification of Lipids in Deep TissueUltrasound in Medicine & Biology 2021;  doi: 10.1016/j.ultrasmedbio.2021.03.005
49
Gerhard Nygaard. On a Novel, Simplified Model Framework Describing Ascorbic Acid Concentration Dynamics2019 41st Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) 2019; : 2880 doi: 10.1109/EMBC.2019.8857675
50
Jiajia Yang, Liwu Lin, Ensheng Xue, Dengke Hong, Yan Yang, Meifang Xu, Zhikui Chen. Can Nonfibrotic Nonalcoholic Steatohepatitis Be Effectively Identified by Supersonic Shear Imaging?Analytical Cellular Pathology 2019; 2019: 1 doi: 10.1155/2019/2013674
51
Mayur Virarkar, Janio Szklaruk, Corey T. Jensen, Melissa W. Taggart, Priya Bhosale. What's New in Hepatic SteatosisSeminars in Ultrasound, CT and MRI 2021;  doi: 10.1053/j.sult.2021.03.001
52
Haiyan Chen, Siqi Dai, Yimin Fang, Liubo Chen, Kai Jiang, Qichun Wei, Kefeng Ding. Hepatic Steatosis Predicts Higher Incidence of Recurrence in Colorectal Cancer Liver Metastasis PatientsFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.631943
53
Fabio Lucio Stahlschmidt, Jean Rodrigo Tafarel, Carla Martinez Menini-Stahlschmidt, Cristina Pellegrino Baena, Guy Cloutier. Hepatorenal index for grading liver steatosis with concomitant fibrosisPLOS ONE 2021; 16(2): e0246837 doi: 10.1371/journal.pone.0246837
54
Mohammad E. Khamseh, Mojtaba Malek, Rowshanak Abbasi, Hoda Taheri, Maryam Lahouti, Fariba Alaei-Shahmiri. Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/ObesityMetabolic Syndrome and Related Disorders 2021; 19(3): 167 doi: 10.1089/met.2020.0109
55
Zaki A. Sherif. Nonalcoholic Fatty Liver Disease - An Update2019;  doi: 10.5772/intechopen.85780
56
Isabel Molwitz, Miriam Leiderer, Cansu Özden, Jin Yamamura. Dual-Energy Computed Tomography for Fat Quantification in the Liver and Bone Marrow: A Literature ReviewRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren 2020; 192(12): 1137 doi: 10.1055/a-1212-6017
57
Venkatram Krishnan. Response to a letter to the editorAbdominal Radiology 2021; 46(2): 845 doi: 10.1007/s00261-020-02697-y
58
Stefano Ballestri, Fabio Nascimbeni, Simonetta Lugari, Amedeo Lonardo, Giampiero Francica. A critical appraisal of the use of ultrasound in hepatic steatosisExpert Review of Gastroenterology & Hepatology 2019; 13(7): 667 doi: 10.1080/17474124.2019.1621164
59
Rui Zhan, Rongxing Qi, Sheng Huang, Yang Lu, Xiaoyu Wang, Jiashen Jiang, Xiwu Ruan, Anyi Song. The correlation between hepatic fat fraction evaluated by dual-energy computed tomography and high-risk coronary plaques in patients with non-alcoholic fatty liver diseaseJapanese Journal of Radiology 2021;  doi: 10.1007/s11604-021-01113-9
60
Niki Katsiki, Amalia Gastaldelli, Dimitri P. Mikhailidis. Predictive models with the use of omics and supervised machine learning to diagnose non-alcoholic fatty liver disease: A “non-invasive alternative” to liver biopsy?Metabolism 2019; 101: 154010 doi: 10.1016/j.metabol.2019.154010
61
Naoki Tanaka, Takefumi Kimura, Naoyuki Fujimori, Tadanobu Nagaya, Michiharu Komatsu, Eiji Tanaka. Current status, problems, and perspectives of non-alcoholic fatty liver disease researchWorld Journal of Gastroenterology 2019; 25(2): 163-177 doi: 10.3748/wjg.v25.i2.163
62
Jitka Starekova, Scott B. Reeder. Liver fat quantification: where do we stand?Abdominal Radiology 2020; 45(11): 3386 doi: 10.1007/s00261-020-02783-1
63
Suguru Ikeda, Takaaki Sugihara, Yoshiki Hoshino, Yukako Matsuki, Takakazu Nagahara, Jun-ichi Okano, Sonoko Kitao, Youhei Fujioka, Kazuhiro Yamamoto, Hajime Isomoto. Pemafibrate Dramatically Ameliorated the Values of Liver Function Tests and Fibrosis Marker in Patients with Non-Alcoholic Fatty Liver DiseaseYonago Acta Medica 2020; 63(3): 188 doi: 10.33160/yam.2020.08.009